Care guide / Question worksheet
Name the product. Then check its status.
Get the ingredient name, meaning the substance in the medicine. Ask whether the product is a shot, a pill or something else. Then ask why it is being offered.
If this is where you are
A page uses words like custom or research. You want to know whether that means the medicine has been reviewed. Those words need unpacking.
The terms, without the fog
The US agency that reviews medicines is the Food and Drug Administration, or FDA.
What is a peptide?
Picture a peptide as beads joined into a small chain. The beads stand for tiny parts that also make up proteins. Insulin is a peptide, for example.
FDA / The context for peptide medicinesWhat does compounded mean?
Compounding is the making or mixing of a medicine by a pharmacist or doctor to meet a patient’s needs.
FDA / What compounding involvesHas a compounded medicine passed FDA review?
At the September 26, 2026, check, compounded medicines were not FDA-approved. The agency had not checked their safety, how well they worked or their quality before they reached patients.
FDA / The limits of its reviewAsk which product you would receive
Ask for the exact product, not just the word peptide.
As of September 26, 2026, US law allowed medicines to be made to order when the compounding rules were met. That did not permit every ingredient.
FDA / Compounding has conditions, not blanket permissionFor a regular pharmacy, a raw ingredient must meet the official medicine standards if those exist. If there are no such standards, the ingredient must be in a medicine with FDA approval. When neither condition applies, the ingredient must appear on the FDA’s list of allowed extra ingredients.
FDA / The ingredient checks for a regular pharmacyThese are ingredient checks, not every rule a pharmacy must meet. Ask which ingredient rule allows this product and what other compounding rules apply.
Semaglutide (Ozempic, Wegovy) had FDA approval for specific medical uses as of September 26, 2026. These included diabetes or weight management, depending on the product.
FDA / What the approved product is meant to treatA check of FDA records on September 26, 2026, found no approved US medicine for BPC-157, ipamorelin or MOTS-c.
FDA / Product approval recordsApproval of a different medicine does not answer your question about this one. Ask the prescriber, the person who writes the medicine order, to explain whether this exact product is approved for the reason you would take it.
Taking a request back does not grant permission
A request asks the FDA to consider an ingredient for compounding. Withdrawn means the group took its request back.
On the FDA ingredient page checked on September 26, 2026, requests to allow BPC-157 and MOTS-c in made-to-order medicines had been taken back. The FDA still listed safety concerns for both.
FDA / Requests taken back and concerns still listedAs of September 26, 2026, the FDA cited concerns that some injected peptides could make the body react against them. It also warned that it can be hard to check exactly what is in them. For some peptides, it had little or no safety information from use in people.
FDA / Why questions remain about injected peptidesAsk what problems are known for your exact product. Ask what is still unknown and who to contact if a problem occurs.
As of September 26, 2026, taking back a request did not give permission to make that peptide into a made-to-order medicine.
FDA / The ingredient rules still have to be metMy product card
Keep the words as given. Mark anything that still needs an explanation.
Saving keeps your question notes in this browser only. They are not sent anywhere. Leave private health details out of a shared browser.
Nothing saved on this page yet.